Literature DB >> 9917117

A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.

P T Sawicki1.   

Abstract

CONTEXT: Control of oral anticoagulation therapy has been reported to often be inadequate. Previous retrospective investigations suggest that patients' self-adjustment of oral anticoagulants may lead to improved control.
OBJECTIVE: To investigate the effects of patients' self-management of oral anticoagulation therapy on accuracy of control and measures of treatment-related quality of life.
DESIGN: Randomized, single-blind, multicenter trial. SETTING AND PARTICIPANTS: A total of 179 patients receiving long-term oral anticoagulation treatment were enrolled at 5 referral centers in Germany. INTERVENTION: Patients were randomized to an oral anticoagulation self-management group based on a structured treatment and teaching program and international normalized ratio (INR) self-monitoring. The control group received conventional care as provided by family physicians, including referral to specialists if necessary. MAIN OUTCOME MEASURES: Deviation of INR values from the individual INR target range (squared) and the 5 categories of treatment-related quality of life.
RESULTS: Deviation of INR value from the mean of the INR target range was significantly lower in the intervention group at 3-month (squared INR deviation, 0.59 vs 0.95; P<.001) and 6-month follow-up (0.65 vs 0.83; P=.03) compared with the control group. Also, the intervention group had INR values within the target range more often (repeated measurement analysis for categorical data, P=.006). The results were mainly due to less frequent suboptimal INR values in the intervention group (32.8% vs 50.0% [P=.03] at 3-month, and 33.7% vs 48.2% [P=.08] at 6-month follow-up). Treatment-related quality-of-life measures, especially treatment satisfaction scores, were significantly higher in the intervention group compared with controls.
CONCLUSIONS: An anticoagulation education program that includes self-management of anticoagulation therapy results in improved accuracy of anticoagulation control and in treatment-related quality-of-life measures. Further studies are needed to describe whether the program will reduce risk of bleeding or thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9917117     DOI: 10.1001/jama.281.2.145

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  90 in total

Review 1.  Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.

Authors:  C Gohlke-Bärwolf
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 2.  Home monitoring and management of warfarin therapy: an anticoagulation clinic perspective.

Authors:  T L Stuart
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

3.  Recommendations for patients undertaking self management of oral anticoagulation.

Authors:  D A Fitzmaurice; S J Machin
Journal:  BMJ       Date:  2001-10-27

Review 4.  Anticoagulation in patients with thromboembolic disease.

Authors:  R C Tait
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 5.  Point of care testing.

Authors:  C P Price
Journal:  BMJ       Date:  2001-05-26

Review 6.  Home international normalized ratio monitoring: where evidence-based medicine is exemplified in the Medicare coverage process.

Authors:  Mitchell I Burken; John J Whyte
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300

Review 7.  A systematic review of outcome measures reported for the therapeutic effectiveness of oral anticoagulation.

Authors:  D A Fitzmaurice; P Kesteven; K M Gee; E T Murray; R McManus
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

8.  Training for patients in a randomised controlled trial of self management of warfarin treatment.

Authors:  Ellen Murray; David Fitzmaurice; Debbie McCahon; Chris Fuller; Hardeep Sandhur
Journal:  BMJ       Date:  2004-02-21

9.  Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.

Authors:  J B Segal; R L McNamara; M R Miller; N Kim; S N Goodman; N R Powe; K A Robinson; E B Bass
Journal:  J Gen Intern Med       Date:  2000-01       Impact factor: 5.128

10.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.